REPORT ID 6500

United States Cannabidiol (CBD) Market Report 2017

Publish Date
26-Dec-17
Pages
105
Format
Electronic (PDF)

In this report, the United States Cannabidiol (CBD) market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Cannabidiol (CBD) in these regions, from 2012 to 2022 (forecast).

United States Cannabidiol (CBD) market competition by top manufacturers/players, with Cannabidiol (CBD) sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    ENDOCA
    CBD American Shaman
    Gaia Botanicals
    Isodiol
    Medical Marijuana
    Aurora Cannabis (AC)
    Cannoid
    Canopy Growth Corporation
    CV Sciences
    IRIE CBD
    Elixinol
    NuLeaf Naturals
    PharmaHemp
    Folium Biosciences

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Food Grade
    Pharmaceutical Grade
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Anxiety
    Fibromyalgia (FM)
    Diabetes
    Other

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Cannabidiol (CBD) Market Report 2017
1 Cannabidiol (CBD) Overview
    1.1 Product Overview and Scope of Cannabidiol (CBD)
    1.2 Classification of Cannabidiol (CBD) by Product Category
        1.2.1 United States Cannabidiol (CBD) Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Cannabidiol (CBD) Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 Food Grade
        1.2.4 Pharmaceutical Grade
    1.3 United States Cannabidiol (CBD) Market by Application/End Users
        1.3.1 United States Cannabidiol (CBD) Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Anxiety
        1.3.3 Fibromyalgia (FM)
        1.3.4 Diabetes
        1.3.5 Other
    1.4 United States Cannabidiol (CBD) Market by Region
        1.4.1 United States Cannabidiol (CBD) Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Cannabidiol (CBD) Status and Prospect (2012-2022)
        1.4.3 Southwest Cannabidiol (CBD) Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Cannabidiol (CBD) Status and Prospect (2012-2022)
        1.4.5 New England Cannabidiol (CBD) Status and Prospect (2012-2022)
        1.4.6 The South Cannabidiol (CBD) Status and Prospect (2012-2022)
        1.4.7 The Midwest Cannabidiol (CBD) Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Cannabidiol (CBD) (2012-2022)
        1.5.1 United States Cannabidiol (CBD) Sales and Growth Rate (2012-2022)
        1.5.2 United States Cannabidiol (CBD) Revenue and Growth Rate (2012-2022)

2 United States Cannabidiol (CBD) Market Competition by Players/Suppliers
    2.1 United States Cannabidiol (CBD) Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Cannabidiol (CBD) Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Cannabidiol (CBD) Average Price by Players/Suppliers (2012-2017)
    2.4 United States Cannabidiol (CBD) Market Competitive Situation and Trends
        2.4.1 United States Cannabidiol (CBD) Market Concentration Rate
        2.4.2 United States Cannabidiol (CBD) Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Cannabidiol (CBD) Manufacturing Base Distribution, Sales Area, Product Type

3 United States Cannabidiol (CBD) Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Cannabidiol (CBD) Sales and Market Share by Region (2012-2017)
    3.2 United States Cannabidiol (CBD) Revenue and Market Share by Region (2012-2017)
    3.3 United States Cannabidiol (CBD) Price by Region (2012-2017)

4 United States Cannabidiol (CBD) Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Cannabidiol (CBD) Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Cannabidiol (CBD) Revenue and Market Share by Type (2012-2017)
    4.3 United States Cannabidiol (CBD) Price by Type (2012-2017)
    4.4 United States Cannabidiol (CBD) Sales Growth Rate by Type (2012-2017)

5 United States Cannabidiol (CBD) Sales (Volume) by Application (2012-2017)
    5.1 United States Cannabidiol (CBD) Sales and Market Share by Application (2012-2017)
    5.2 United States Cannabidiol (CBD) Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Cannabidiol (CBD) Players/Suppliers Profiles and Sales Data
    6.1 ENDOCA
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Cannabidiol (CBD) Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 ENDOCA Cannabidiol (CBD) Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 CBD American Shaman
        6.2.2 Cannabidiol (CBD) Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 CBD American Shaman Cannabidiol (CBD) Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Gaia Botanicals
        6.3.2 Cannabidiol (CBD) Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Gaia Botanicals Cannabidiol (CBD) Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Isodiol
        6.4.2 Cannabidiol (CBD) Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Isodiol Cannabidiol (CBD) Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Medical Marijuana
        6.5.2 Cannabidiol (CBD) Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Medical Marijuana Cannabidiol (CBD) Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Aurora Cannabis (AC)
        6.6.2 Cannabidiol (CBD) Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Aurora Cannabis (AC) Cannabidiol (CBD) Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Cannoid
        6.7.2 Cannabidiol (CBD) Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Cannoid Cannabidiol (CBD) Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Canopy Growth Corporation
        6.8.2 Cannabidiol (CBD) Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Canopy Growth Corporation Cannabidiol (CBD) Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 CV Sciences
        6.9.2 Cannabidiol (CBD) Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 CV Sciences Cannabidiol (CBD) Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 IRIE CBD
        6.10.2 Cannabidiol (CBD) Product Category, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 IRIE CBD Cannabidiol (CBD) Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 Elixinol
    6.12 NuLeaf Naturals
    6.13 PharmaHemp
    6.14 Folium Biosciences

7 Cannabidiol (CBD) Manufacturing Cost Analysis
    7.1 Cannabidiol (CBD) Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Cannabidiol (CBD)

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Cannabidiol (CBD) Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Cannabidiol (CBD) Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Cannabidiol (CBD) Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Cannabidiol (CBD) Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Cannabidiol (CBD) Sales Volume Forecast by Type (2017-2022)
    11.3 United States Cannabidiol (CBD) Sales Volume Forecast by Application (2017-2022)
    11.4 United States Cannabidiol (CBD) Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer